Y 25510

TargetMol
Product Code: TAR-T35227
Supplier: TargetMol
CodeSizePrice
TAR-T35227-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Y 25510 is a biochemical.
CAS:
145194-32-7
Formula:
C19H22N4O3
Molecular Weight:
354.41
Purity:
0.98
SMILES:
CC(CN(C)C)Oc1ccc(cc1)-c1nn(CC(O)=O)c2ncccc12

References

Kusuhara H, Komatsu H, Hisadome M, Ikeda Y. (+/-)-3-[4-(2-dimethylamino-1-methylethoxy)-phenyl]-1H-pyrazolo[3,4- B]pyridine-1-acetic acid (Y-25510) stimulates production of IL-1 beta and IL-6 at the level of messenger RNA expression in cultured human monocytes. Int J Immunopharmacol. 1996 Dec;18(12):719-28. PubMed PMID: 9172015. Azuma J, Ogura M, Yamamoto I, Hisadome M, Fukuda T, Ikeda Y, Mori H, Oka T, Asano S. The effect of Y-25510 injection on the serum levels of some cytokines in healthy adult volunteers. Eur J Clin Pharmacol. 1998 Feb;53(6):411-9. PubMed PMID: 9551699. Hisadome M, Fukuda T, Terasawa M, Oe T, Takahata H, Goto K, Tsuru S, Nomoto K. Enhancement of host defense by Y-25510, (+-)-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4 -b] pyridine-1-acetic acid, a novel synthetic compound. A comparison with recombinant human granulocyte colony-stimulating factor in 5-fluorouracil-treated mice. Int J Immunopharmacol. 1992 Oct;14(7):1195-201. PubMed PMID: 1280628. Hisadome M, Fukuda T, Matsuyuki H, Ikeda Y, Nomoto K. Enhancement of in vivo production of IL-1 alpha and IL-6 in mice by Y-25510, a 1H-pyrazolo[3,4-b]pyridine-1 acetic acid derivative. Int J Immunopharmacol. 1996 Jun-Jul;18(6-7):379-84. PubMed PMID: 9024939.